Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo

Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo

(2012) P. Rajendran et al.   Cancer Prevention Research

Involvement of c-Met- and Phosphatidylinositol 3-Kinase Dependent Pathways in Arsenite-Induced Downregulation of Catalase in Hepatoma Cells

(2011) Soohee Kim et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-ĸB-mediated Matrix Metalloproteinase-9 Expression

(2011) Yoonseo Kim et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine

(2011) Timothy A. Yap et al.   CURRENT DRUG TARGETS

Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET

(2011) Barbara Grzelakowska-Sztabert et al.   GROWTH FACTORS

c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma

(2011) Hanning You et al.   HEPATOLOGY

Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures

(2011) Masahiro Tanaka et al.   JOURNAL OF EPIDEMIOLOGY

Current Situation of Hepatocellular Carcinoma in Mongolia

(2011) Oidov Baatarkhuu et al.   ONCOLOGY

Targeting MET by Tyrosine Kinase Inhibitor Suppresses Growth and Invasion of Nasopharyngeal Carcinoma Cell Lines

(2011) Patrick C. Lau et al.   PATHOLOGY & ONCOLOGY RESEARCH

c-MET as a potential therapeutic target and biomarker in cancer

(2011) J. Rafael Sierra et al.   Therapeutic Advances in Medical Oncology

Targeting the HGF/c-Met Axis: State of Play

(2010) T. A. Yap et al.   MOLECULAR CANCER THERAPEUTICS